Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
Item | Description | The company |
---|---|---|
EBITDA | To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital. | AmerisourceBergen Corp. EBITDA increased from 2020 to 2021 and from 2021 to 2022. |
Enterprise Value to EBITDA Ratio, Current
Selected Financial Data (US$ in thousands) | |
Enterprise value (EV) | 41,299,807) |
Earnings before interest, tax, depreciation and amortization (EBITDA) | 3,124,874) |
Valuation Ratio | |
EV/EBITDA | 13.22 |
Benchmarks | |
EV/EBITDA, Competitors1 | |
Abbott Laboratories | 21.76 |
Cigna Group | 10.71 |
CVS Health Corp. | 6.70 |
Elevance Health Inc. | 7.79 |
Intuitive Surgical Inc. | 83.53 |
Medtronic PLC | 16.39 |
UnitedHealth Group Inc. | 14.59 |
EV/EBITDA, Sector | |
Health Care Equipment & Services | 15.42 |
EV/EBITDA, Industry | |
Health Care | 15.36 |
Based on: 10-K (reporting date: 2022-09-30).
1 Click competitor name to see calculations.
If the company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.
Otherwise, if the company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.
Enterprise Value to EBITDA Ratio, Historical
Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | |||||||
Enterprise value (EV)1 | 36,473,156) | 30,235,610) | 20,514,111) | 18,995,014) | 20,769,340) | 18,335,740) | |
Earnings before interest, tax, depreciation and amortization (EBITDA)2 | 3,124,874) | 2,919,189) | (4,727,296) | 1,660,092) | 1,877,172) | 1,499,260) | |
Valuation Ratio | |||||||
EV/EBITDA3 | 11.67 | 10.36 | — | 11.44 | 11.06 | 12.23 | |
Benchmarks | |||||||
EV/EBITDA, Competitors4 | |||||||
Abbott Laboratories | 15.85 | 17.42 | 25.99 | 21.70 | — | — | |
Cigna Group | 8.88 | 9.06 | 6.31 | 8.42 | — | — | |
CVS Health Corp. | 12.42 | 10.41 | 8.56 | 9.43 | — | — | |
Elevance Health Inc. | 10.26 | 10.05 | 7.57 | 9.05 | — | — | |
Intuitive Surgical Inc. | 41.52 | 44.54 | 59.12 | 37.53 | — | — | |
Medtronic PLC | 14.99 | 24.41 | 17.92 | 16.01 | — | — | |
UnitedHealth Group Inc. | 15.11 | 17.39 | 13.39 | 13.82 | — | — | |
EV/EBITDA, Sector | |||||||
Health Care Equipment & Services | 13.98 | 15.40 | 13.12 | — | — | — | |
EV/EBITDA, Industry | |||||||
Health Care | 13.71 | 13.87 | 16.50 | — | — | — |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
3 2022 Calculation
EV/EBITDA = EV ÷ EBITDA
= 36,473,156 ÷ 3,124,874 = 11.67
4 Click competitor name to see calculations.